Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease With and Without Down's Syndrome-Reference-Cited by-同舟云学术

Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease With and Without Down's Syndrome

Published:2009-05 Issue:9 Volume:103 Page:1309-1315
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Duffels Mariëlle G.J.,Vis Jeroen C.,van Loon Rosa L.E.,Nieuwkerk Pythia T.,van Dijk Arie P.J.,Hoendermis Elke S.,de Bruin-Bon Rianne H.A.C.M.,Bouma Berto J.,Bresser Paul,Berger Rolf M.F.,Mulder Barbara J.M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Bosentan Randomized Trial of Endothelin Antagonist Therapy;Galie;Circulation,2006

2. Survival with first-line bosentan in patients with primary pulmonary hypertension;McLaughlin;Eur Respir J,2005

3. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension;Provencher;Eur Heart J,2006

4. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study;Sitbon;Chest,2003

5. Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan;Keogh;J Heart Lung Transplant,2007

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Pediatric Pulmonary Hypertension: Implications for Diagnosis and Treatment;Clinical Therapeutics;2023-09

2. A slightly adapted treadmill protocol for the determination of maximal oxygen uptake in adults with Down syndrome;Journal of Applied Research in Intellectual Disabilities;2023-06-29

3. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus;Circulation;2023-01-31

4. The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience;The Anatolian Journal of Cardiology;2022-10-03

5. Targeted Therapies in Patients with Pulmonary Arterial Hypertension Due to Congenital Heart Disease;Current Vascular Pharmacology;2022-07